feed,title,long_url,short_url
Benzinga,Cytokinetics Plans To Discontinue Late-Stage ALS Trial Due To Futility,https://benzinga.com/general/biotech/23/03/31610820/cytokinetics-plans-to-discontinue-late-stage-als-trial-due-to-futility,https://da.gd/sQk1IH
